Emerging procedure reduces circulation concerns by 50% in patients wi… | HappeningNow.news
Published Date: April 23, 2026

Emerging procedure reduces circulation concerns by 50% in patients with no-option chronic limb-threatening ischemia

Data from the PROMISE III trial suggest that chronic limb-threatening ischemia (CLTI) patients with no other treatment options experienced significant quality of life (QoL) improvements after undergoing transcatheter arterialization of the deep veins (TADV).

Health Medicalxpress

AI Summary Powered by HappeningNow

Data from the PROMISE III trial suggest that chronic limb-threatening ischemia (CLTI) patients with no other treatment options experienced significant quality of life (QoL) improvements after undergoing transcatheter arterialization of the deep veins (TADV).

AI summaries can be wrong sometimes—always verify important details using the source link below.

Read full article at medicalxpress.com
Category Health
Outlet Medicalxpress
Source medicalxpress.com
Return Home